NYSE:ABT

Giving Kids With Heart Failure a Brighter Future

Katrina Sellens was 14 when a heart pump saved her life. With FDA approval, more kids can benefit from HeartMate 3.
Multimedia with summary

A few years ago, Katrina Sellens — 14 and hungry for Thanksgiving leftovers — stood there in a familiar spot: Surveying the fridge for something to eat.

What happened next was also recognizable to Katrina and her family.

She passed out.

Breaking Down Barriers, Advancing Health Equity

Blog

Waking up each day with good health is something people no longer take for granted. But, the reality is, there are vast disparities in who has good health, and who doesn’t.

Easterseals and the Abbott Fund Join Together to Advance Health Equity Through the Black Child Fund

Support for the Easterseals Black Child Fund Will Advance Early Identification and Interventions Among Black Children to Reduce Health Disparities Often Experienced in Early Childhood
Press Release

CHICAGO, February 1, 2021 /3BL Media/ – The Abbott Fund, the foundation of the global healthcare company Abbott, is the first funder to support Easterseals' newly established Black Child Fund, with a $250,000 grant to advance health equity by addressing racial disparities in healthcare among young Black children with autism and other disabilities. The Easterseals Black Child Fund has been established to provide timely diagnosis and appropriate care to help address these longstanding disparities, which have been exacerbated by the COVID-19 pandemic.

Time to Bridge the Gap, Demand Diabetes Care Equity

Access to breakthrough tech remain out of reach for many who stand to benefit most. Something has to change.
Summary: 

Tracey D. Brown, who lives with type 2 diabetes, is CEO of the American Diabetes Association, the nation's largest voluntary health organization and a global authority on diabetes. Jared Watkin is Senior Vice President, Diabetes Care, at Abbott, a leading global health technology company. Their op-ed, republished here, originally appeared in the Boston Herald.

Article

Tracey D. Brown, who lives with type 2 diabetes, is CEO of the American Diabetes Association, the nation's largest voluntary health organization and a global authority on diabetes. Jared Watkin is Senior Vice President, Diabetes Care, at Abbott, a leading global health technology company. Their op-ed, republished here, originally appeared in the Boston Herald.

Abbott's BinaxNOW, FreeStyle Libre 2 Win BIG Innovation Honors

At-home COVID-19 test, groundbreaking glucose monitoring system among Business Intelligence Group's best of 2021.
Blog

We promise, we're not going to make too big of a deal of winning any award. But this news is definitely two BIG to keep quiet about.

Abbott Receives FDA 510(K) Clearance for the First Rapid Handheld Blood Test for Concussions

Summary: 
  • The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott's i-STAT™ Alinity™ handheld device
  • Having a blood test available could help eliminate wait time in the emergency room and could reduce the number of unnecessary CT scans by up to 40%
  • The test simultaneously measures biomarkers UCH-L1 and GFAP, proteins found in the blood after a concussion or head trauma
  • Building on this initial clearance, Abbott is also working on a test that would use whole blood on i-STAT at the point of care, and developing a test for its Alinity™ i and ARCHITECT® core laboratory instruments under FDA breakthrough designation
Press Release
  • The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott's i-STAT™ Alinity™ handheld device
  • Having a blood test available could help eliminate wait time in the emergency room and could reduce the number of unnecessary CT scans by up to 40%
  • The test simultaneously measures biomarkers UCH-L1 and GFAP, proteins found in the blood after a concussion or head trauma
  • Building on this initial clearance, Abbott is also working on a test that would use whole blood on i-STAT at the point of care, and developing a test for its Alinity™ i and ARCHITECT® core laboratory instruments under FDA breakthrough designation

FDA Approves Labeling Update for Abbott's Heartmate 3 Heart Pump for Use in Pediatric Patients

Summary: 
  • Abbott's HeartMate 3™ heart pump approved for use for pediatric patients battling advanced heart failure
  • This life-saving technology provides new treatment option for underserved population

 

Press Release
  • Abbott's HeartMate 3™ heart pump approved for use for pediatric patients battling advanced heart failure
  • This life-saving technology provides new treatment option for underserved population

 

A Sustainable Future Starts With Health: Abbott Launches New 2030 Sustainability Plan

Abbott’s 2030 Sustainability Plan has a clear priority: designing our life-changing technologies for access and affordability.
Blog

A sustainable future starts with health. 

Health is the foundation for everything else. For people to thrive. To be empowered. To live the lives they want to live. It helps communities and economies to prosper and is vital to building better, healthier societies.

Abbott Named Industry Sustainability Leader for the Eighth Year in a Row on the Dow Jones Sustainability Index (DJSI)

Summary: 
  • Abbott achieves top industry scores in governance/economic and social performance, earns more than triple the average industry score in its industry sector
  • Company recognized for sustainability on DJSI for 16 consecutive years
  • Abbott to introduce its 2030 sustainability plan later this year
Press Release
  • Abbott achieves top industry scores in governance/economic and social performance, earns more than triple the average industry score in its industry sector
  • Company recognized for sustainability on DJSI for 16 consecutive years
  • Abbott to introduce its 2030 sustainability plan later this year

Abbott Launches New Digital Site to Share Updates on Sustainability and Social Impact

Multimedia with summary

Abbott recently launched a new digital site – Abbott.com/Responsibility  – to better communicate its work to deliver positive impact through sustainable business.

The new site includes engaging stories, videos and photos that show the positive human impact of Abbott’s work across its businesses and in partnership with others. You'll also find data, facts and graphics that demonstrate the company's progress in delivering strong economic, social and environmental results. A few examples:

Pages

Subscribe to NYSE:ABT